Binding to serine 65‐phosphorylated ubiquitin primes Parkin for optimal PINK1‐dependent phosphorylation and activation

Abstract

Mutations in the mitochondrial protein kinase PINK1 are associated with autosomal recessive Parkinson disease (PD). We and other groups have reported that PINK1 activates Parkin E3 ligase activity both directly via phosphorylation of Parkin serine 65 (Ser 65 )—which lies within its ubiquitin‐like domain (Ubl)—and indirectly through phosphorylation of ubiquitin at Ser 65 . How Ser 65 ‐phosphorylated ubiquitin (ubiquitin Phospho‐Ser65 ) contributes to Parkin activation is currently unknown. Here, we demonstrate that ubiquitin Phospho‐Ser65 binding to Parkin dramatically increases the rate and stoichiometry of Parkin phosphorylation at Ser 65 by PINK1 in vitro . Analysis of the Parkin structure, corroborated by site‐directed mutagenesis, shows that the conserved His302 and Lys151 residues play a critical role in binding of ubiquitin Phospho‐Ser65 , thereby promoting Parkin Ser 65 phosphorylation and activation of its E3 ligase activity in vitro . Mutation of His302 markedly inhibits Parkin Ser 65 phosphorylation at the mitochondria, which is associated with a marked reduction in its E3 ligase activity following mitochondrial depolarisation. We show that the binding of ubiquitin Phospho‐Ser65 to Parkin disrupts the interaction between the Ubl domain and C‐terminal region, thereby increasing the accessibility of Parkin Ser 65 . Finally, purified Parkin maximally phosphorylated at Ser 65 in vitro cannot be further activated by the addition of ubiquitin Phospho‐Ser65 . Our results thus suggest that a major role of ubiquitin Phospho‐Ser65 is to promote PINK1‐mediated phosphorylation of Parkin at Ser 65 , leading to maximal activation of Parkin E3 ligase activity. His302 and Lys151 are likely to line a phospho‐Ser 65 ‐binding pocket on the surface of Parkin that is critical for the ubiquitin Phospho‐Ser65 interaction. This study provides new mechanistic insights into Parkin activation by ubiquitin Phospho‐Ser65 , which could aid in the development of Parkin activators that mimic the effect of ubiquitin Phospho‐Ser65 .

Cited by papers we hold 20

• The mitophagy pathway and its implications in human diseases · 2023
  No notice
• Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications · 2023
  No notice
• Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation · 2023
  No notice
• Mitophagy: Molecular Mechanisms, New Concepts on Parkin Activation and the Emerging Role of AMPK/ULK1 Axis · 2021
  No notice
• Molecular mechanisms and physiological functions of mitophagy · 2021
  No notice
• Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury · 2021
  No notice
• Critical role of mitochondrial ubiquitination and the OPTN–ATG9A axis in mitophagy · 2020
  No notice
• The Role of Autophagy and Mitophagy in Bone Metabolic Disorders · 2020
  No notice
• AMPK activation induces mitophagy and promotes mitochondrial fission while activating TBK1 in a PINK1‐Parkin independent manner · 2020
  No notice
• PINK1/PARKIN signalling in neurodegeneration and neuroinflammation · 2020
  No notice
• Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling · 2020
  No notice
• Mitophagy, Mitochondrial Homeostasis, and Cell Fate · 2020
  No notice
• The Emerging Role of the Lysosome in Parkinson’s Disease · 2020
  No notice
• PINK1/Parkin Mediated Mitophagy, Ca2+ Signalling, and ER–Mitochondria Contacts in Parkinson’s Disease · 2020
  No notice
• Parkin recruitment to impaired mitochondria for nonselective ubiquitylation is facilitated by MITOL · 2019
  No notice
• Phosphorylation of Parkin at serine 65 is essential for its activation in vivo · 2018
  No notice
• PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1–Parkin-mediated mitophagy · 2018
  Corrected
• Mitochondrial quality control in amyotrophic lateral sclerosis: towards a common pathway? · 2017
  Not checked
• Ubiquitin modifications · 2016
  No notice
• Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1 · 2015
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.